IPSC stock Statistics — Century Therapeutics, Inc. filings, insiders & smart money

Earnings12 Nov 2026

52-week rangeSign inDay rangeSign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-08-03 · filed common shares: 181.07M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 2.57%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 16.31%
Short ratioDays to cover, as published by FINRA: 70.64
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 54.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 42.70%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross margin: —
Operating marginFY Dec 25: -15.82%
Net margin: —
EBITDA marginFY Dec 25: -3.82%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -49.65%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -38.41%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

-0.93

EPS (fwd)

Cash & equivalentsas of Jun 26: $49.64M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $38.66M
Debt / equityas of Jun 26: 16.64%
Current ratioas of Jun 26: 8.28
Quick ratio: —
Operating cash flowTTM to Jun 26: -$86.75M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$88.09M
TTM revenue / diluted share: —